Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Editorial: defining a microbial signature to predict non-response to a low FODMAP diet-a step closer or is it? Authors' reply.

Literature DB >> 33566399

Editorial: defining a microbial signature to predict non-response to a low FODMAP diet-a step closer or is it? Authors' reply.

Bruno Pedro Chumpitazi^1,2, Robert J Shulman^1,2.

Abstract

Entities: Chemical

Mesh：

Substances：
Fructans

Year: 2021 PMID： 33566399 PMCID： PMC8268964 DOI： 10.1111/apt.16244

Source DB: PubMed Journal: Aliment Pharmacol Ther ISSN： 0269-2813 Impact factor: 8.171

Keyword Cloud
References

× No keyword cloud information.

10 in total

1. Nocebo effects in multiple sclerosis trials: a meta-analysis.

Authors: D Papadopoulos; D D Mitsikostas
Journal: Mult Scler Date: 2010-06-10 Impact factor: 6.312

2. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.

Authors: Jørgen Valeur; Milada Cvancarova Småstuen; Torunn Knudsen; Gülen Arslan Lied; Arne Gustav Røseth
Journal: Dig Dis Sci Date: 2018-01-04 Impact factor: 3.199

3. Editorial: defining a microbial signature to predict non-response to a FODMAP diet-a step closer or is it?

Authors: Emma P Halmos
Journal: Aliment Pharmacol Ther Date: 2021-03 Impact factor: 8.171

Review 4. Recommendations for pharmacological clinical trials in children with irritable bowel syndrome: the Rome foundation pediatric subcommittee on clinical trials.

Authors: M Saps; M A L van Tilburg; J V Lavigne; A Miranda; M A Benninga; J A Taminiau; C Di Lorenzo
Journal: Neurogastroenterol Motil Date: 2016-07-31 Impact factor: 3.598

Review 5. The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.

Authors: Bruno P Chumpitazi
Journal: Curr Opin Gastroenterol Date: 2020-03 Impact factor: 3.287

6. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.

Authors: B P Chumpitazi; J L Cope; E B Hollister; C M Tsai; A R McMeans; R A Luna; J Versalovic; R J Shulman
Journal: Aliment Pharmacol Ther Date: 2015-06-24 Impact factor: 8.171

Editorial: defining a microbial signature to predict non-response to a low FODMAP diet-a step closer or is it? Authors' reply.

1. Nocebo effects in multiple sclerosis trials: a meta-analysis.

2. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.

3. Editorial: defining a microbial signature to predict non-response to a FODMAP diet-a step closer or is it?

Review 4. Recommendations for pharmacological clinical trials in children with irritable bowel syndrome: the Rome foundation pediatric subcommittee on clinical trials.

Review 5. The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.

6. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.

7. Diets that differ in their FODMAP content alter the colonic luminal microenvironment.

8. Fructan-sensitive children with irritable bowel syndrome have distinct gut microbiome signatures.

9. Structure, function and diversity of the healthy human microbiome.

Review 10. Novel study designs to investigate the placebo response.